Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Lyra Therapeutics (NASDAQ:LYRA) through any online brokerage.
Other companies in Lyra Therapeutics’s space includes: Gelteq Ltd (NASDAQ:GELS), Cocrystal Pharma Inc (NASDAQ:COCP), 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP), Addex Therapeutics Ltd (NASDAQ:ADXN) and Kiora Pharmaceuticals Inc (NASDAQ:KPRX).
Lyra Therapeutics has a consensus price target of $11.88.
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $3.75 last updated November 17, 2025 at 7:35 PM EST.
There are no upcoming dividends for Lyra Therapeutics.
Lyra Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Lyra Therapeutics.
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.